KALOBIOS PHARMACEUTICALS INC - FORM 10-Q - EX-32.2 - CERTIFICATION BY THE CHIEF FINANCIAL OFFICER - September 25, 2012
| Attached files | ||||||
| File | Filename | |||||
|---|---|---|---|---|---|---|
| EX-32.1 - CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER - KALOBIOS PHARMACEUTICALS INC | d401713dex321.htm | |||||
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - KALOBIOS PHARMACEUTICALS INC | d401713dex312.htm | |||||
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - KALOBIOS PHARMACEUTICALS INC | d401713dex311.htm | |||||
| EX-4.2 - SPECIMEN OF STOCK CERTIFICATE - KALOBIOS PHARMACEUTICALS INC | d401713dex42.htm | |||||
| 10-Q - FORM 10-Q - KALOBIOS PHARMACEUTICALS INC | d401713d10q.htm | |||||
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kalobios Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jeffrey H. Cooper, the Senior Vice President, Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| September 24, 2012 | /s/ Jeffrey H. Cooper | |||
| Jeffrey H. Cooper Chief Financial Officer (Principal Financial Officer) |
A signed original of this written statement required by Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350), has been provided to KaloBios Pharmaceuticals, Inc. and will be retained by KaloBios Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of KaloBios Pharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
User Contributions:
Comment about this document or add new information about this topic:
This web site and associated pages are not associated with, endorsed by, or sponsored by KALOBIOS PHARMACEUTICALS INC and has no official or unofficial affiliation with KALOBIOS PHARMACEUTICALS INC
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
